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Abstract
A number of important agricultural biotechnology patent disputes have arisen in Canada since the 2004
Supreme Court of Canada decision in Monsanto v. Schmeiser. Typically, defendants no longer contest issues
of patent validity or infringement. Instead, the controversies have shifted to discussions about applicable
remedies for infringement. The Schmeiser case ostensibly marked a fundamental change in the appropriate
method for conducting an accounting of the profits that a defendant infringer must disgorge to a plaintiff
patentee. The remedy of accounting of profits in patent cases, however, remains mired in definitional and
conceptual confusion, which the Schmeiser case has brought to the forefront of disputes. The lack of clarity
and certainty is harmful to all stakeholders in the patent system. This article makes three key contributions in
the field of agricultural biotechnology patents. First, it exposes a largely unrecognized problem pertaining to
the legal remedy of accounting of profits for patent infringement. To address this problem, the article corrects
misunderstandings about recent court decisions pertaining to the accounting of profits remedy. Second, the
article critically examines the discourse used to discuss accounting of profits, which includes sometimes
inconsistent concepts, terms, and definitions. This article proposes strategies to facilitate definitional and
conceptual coherence in order to establish a framework for future jurisprudence and scholarship on this topic.
Finally, the article provides insights into the unsustainability of current trends in this area of law.
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Accounting of Profits to Remedy
Biotechnology Patent Infringement
KURTIS ANDREWS & JEREMY DE BEER*
A number of important agricultural biotechnology patent disputes have arisen in Canada since
the 2004 Supreme Court of Canada decision in Monsanto v. Schmeiser. Typically, defendants
no longer contest issues of patent validity or infringement. Instead, the controversies have
shifted to discussions about appticabte remedies for infringement. The Schmeiser case os-
tensibly marked a fundamental change in the appropriate method for conducting anaccount-
ing of the profits that a defendant infringer must disgorge to a plaintiff patentee. The remedy
of accounting of profits in patent cases, however, remains mired in definitional and conceptual
confusion, which the Schmeiser case has brought to the forefront of disputes. The lack of
clarity and certainty is harmful to all stakeholders in the patent system.
This article makes three key contributions in the field of agricultural biotechnology patents.
First, it exposes a largely unrecognized problem pertaining to the legal remedy of accounting
of profits for patent infringement. To address this problem, the article corrects misunders-
tandings about recent court decisions pertaining to the accounting of profits remedy. Second,
the article critically examines the discourse used to discuss accounting of profits, which in-
ctudes sometimes inconsistent concepts, terms, and definitions. This article proposes strate-
gies to facilitate definitional and conceptual coherence in order to establish a framework
for future jurisprudence and scholarship on this topic. Finally, the article provides insights
into the unsustainability of current trends in this area of law.
Un certain nombre de diff~rends importants en mati~re de brevet de biotechnologie agricole
est survenu au Canada depuis La d~ision de [a Cour supr~me du Canada de 2004 dans
l'affaire de Monsanto c. Schmeiser. En g~n6raL, les d~fendeurs ne contestent plus les ques-
tions de validit6 ou de contrefacon de brevet. Au contraire, les controverses portent d6sor-
mais davantage sur les discussions entourant tes recours applicabtes A [a contrefacon.
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L'affaire Schmeisera marqu6 en apparence un changement fondamentaL dans La fagon ap-
propri6e de remettre les profits qu'un contrefacteur d6fendeur doit verser 6 un demandeur
titulaire d'un brevet. Le recours A La remise des profits dans tes affaires de brevet demeure
.cependant une source de confusion sur les plans de La d~finition et du concept que l'affaire
Schmeiser a port6 h l'avant-sc~ne des diff6rends. Le manque de clart6 et de certitude est
prdjudiciabLe pour tous Les intervenants du syst~me de brevet.
Le pr6sent article apporte trois contributions c6s dans le domaine des brevets de biotechno!o-
gie agricote. Premi6rement, it expose un probtLme en grande partie non reconnu, relatif au
recours judiciaire de La remise des profits en ce qui a trait h La contrefacon de brevet. Afin de
r~gter ce problrme, L'article rectifie Les matentendus au sujet des d6cisions judiciaires r6cen-
tes relatives au recours de ta remise des profits. Deuxi~mement, 'articte jette un regard criti-
que sur le discours employ6 pour traiter de La remise des profits, qui comprend parfois des
concepts, des d6finitions et des termes incoh~rents. Le present article propose des strategies
pour faciliter la coh6rence des definitions et des concepts, 6tabtir un cadre de La jurisprudence
future et une bourse d'6tudes pour ce sujet. En dernier lieu, ['article permet de mieux com-
prendre La non-viabilit6 des tendances actueLtes dans ce domaine du droit.
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A HEADLINE IN THE 20 DECEMBER 2007 edition of The Western Producer de-
clared a stern warning to farmers: "Monsanto wins Ontario patent cases: farm-
ers ordered to pay $160 and $274 per acre for infringement."' The story
reported the outcomes of two "Percy Schmeiser-type"2 court cases, Monsanto
1. Sean Pratt, "Monsanto Wins Ontario Patent Cases" The Western Producer (20 December
2007), online: <http:/www.producer.com/News/Archive-Articde.aspx?aid=221637>.
2. Ibid
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Canada Inc. v. Beneteau3 and Monsanto Canada Inc. v. Wouters,4 which involved
farmers who planted genetically modified soybean seed containing Monsanto's
patented Roundup Ready technology. Mirroring a Monsanto-issued press re-
lease,5 the Western Producer article suggested that Canadian courts are moti-
vated to punish severely farmers who infringe Monsanto's patents. The
reported awards were substantial and the message was clear: if you plant saved
seed containing Monsanto's technology without a licence, you risk dire conse-
quences. Furthermore, the story implied that the cases set strong legal prece-
dents as the only judgments since the Supreme Court of Canada's 2004
decision in Monsanto Canada Inc. v. Schmeiser.6
The article did not, however, accurately portray the awards in light of the
nature of the two judgments: Beneteau was a consent judgment,7 and Wouters
was a default judgment.8 The article also did not attempt to reconcile these
awards with the much lower monetary award granted by the courts in
Schmeiser9 or the legal principles outlined in other Canadian patent infringe-
ment cases. A contextual assessment of these two awards would have revealed
that they were unusually high and inconsistent with other Canadian patent in-
fringement awards. Neither the Beneteau nor the Wouters award reflects what
most plaintiffs should expect to receive, or defendants should expect to pay, in
agricultural biotechnology patent infringement proceedings decided on their
merits.
In December 2008, Monsanto again publicized the high price of infringing
its patents. This time, a press release described settlement terms of $200 per
acre reached with three farmers from Quebec." That announcement came one
3. (27 November 2007), Toronto T-1723-07 (F.C.T.D.) [Beneteau].
4. (2007), 158 A.C.W.S. (3d) 396 (F.C.) [Wouters].
5. Monsanto Canada, News Release, "Ontario Grower Ordered to Pay Monsanto $160 per
acre for Violating Patent Rights on Roundup Ready* Soybeans" (11 December 2007),
online: <http://www.monsanto.ca/about/news/2007/12 11 07.asp> [Monsanto v. Beneteau,
News Release].
6. [2004] 1 S.C.R. 902 [Schmeiser (2004)].
7. Beneteau, supra note 3.
8. Wouters, supra note 4.
9. Monsanto Canada Inc. v. Schmeiser, (2003] 2 F.C. 165 at para. 84 [Schmeiser (2003)];
Schmeiser (2004), supra note 6.
10. Monsanto Canada, News Release, "Quebec Farmers Admit to Patent Violation for Growing
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month before two other infringement actions brought by Monsanto went to
trial: Monsanto Canada Inc. v. Rivett11 and Monsanto Canada Inc. v. Janssens.
1 2
When the decisions in Rivett and Janssens were released in Spring 2009-the
first cases since Schmeiser that were determined on their merits-Monsanto an-
nounced in a stakeholder update that the court had awarded amounts of $66
per acre, $102 per acre, and $185 per acre against the various defendants. 3 The
stakeholder update also repeated the whopping figures of $160 and $274 per
acre from the previously decided Beneteau and Wouters cases.
A closer look at the Rivett and Janssens judgments reveals that the awards
granted by the court are nowhere near the widely publicized outcomes of Wout-
ers, Beneteau, and the Quebec settlements, nor even as high as the amounts
claimed in Monsanto's stakeholder update. Monsanto's figures. combine the
costs and interest awarded in each case with the defendant's per acre profits to
be disgorged. The profits awarded were $42.38 per acre in Rivett1 and an aver-
age of $48.46 per acre, per defendant, in Janssens.5 Schmeiser was ordered to
pay only $19 per acre by the Federal Court of Appeal for his infringement,
which was later reduced to zero by the Supreme Court (albeit because of the
distinctive facts of that case). Monsanto's usual royalty rate for patented seed
technology is, by the way, about $15 per acre. 6 Although Monsanto's reports
are not technically false, the true value of the awards has typically been fairly
small, usually $10,000 or less. In the few cases where defendants paid signifi-
cantly more, the awards would surely have been lower if their cases had been
adequately defended.
Monsanto's Roundup Ready® Technology Without a License" (15 December 2008), online:
<http://www.monsanto.ca/about/news/2008/12_1 508.asp>.
11. (2009), 343 F.T.R. 203 (F.C.) [Rivett].
12. (2009), 343 F.T.R. 234 (F.C.) [anssens].
13. Monsanto Canada, Stakeholder Update, "Federal Court of Canada Orders Ontario Growers to
Pay Monsanto for Patent Infringement Violations" (24 July 2009) [copy on file with author].
14. Rivett, supra note 11 at paras. 76, 102.
15. This number is based on the amended reasons for judgment, issued 10 July 2009. See
Monsanto Canada Inc. v. Janssens (10 July 2009), Toronto T-1 545-05 (F.C.). The amount
reported here is very close to the values set in Janssens, supra note 12 at para. 51.
16. At the material time that the Schmeiser, Rivett, and Janssens infringement allegations arose,
the licensing fee was $15. See "In Depth: Genetic Modification - Percy Schmeiser's Battle"
CBCNews Online (21 May 2004), online: <http://www.cbc.calnews/background/
genetics modification/percyschmeiser.html>. In recent years, the fee system has changed.
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Nevertheless, international newspaper magazines such as The Economist
have been reporting the Rivett and Janssens court decisions as Monsanto's "latest
success in enforcing its stern line."17 When confronted with public information
from Monsanto or the media about the potentially grave consequences of de-
fending an infringement claim, it should be no surprise that farmers are moti-
vated to settle lawsuits early and keep them out of court. This is especially true
for anyone unfamiliar with the legal process or without access to counsel ex-
perienced in patent law, which is the norm for most farmers facing patent in-
fringement claims.
Given the fear among farmers of incurring very high costs to settle agricul-
tural biotechnology patent infringement, the legal system seems to provide an ef-
fective deterrent against infringement and ostensibly promotes licensing. That,
in turn, protects the incentives to develop innovative technologies. Patent
owners, however, should probably be concerned about developments in this
area of the law, while those facing infringement allegations might feel better
about their legal prospects. Publicized information about potential damage
awards, from both the media and Monsanto, can be somewhat misleading.
Moreover, potentially misleading information is not in the best interests of
farmers threatened, rightly or wrongly, with an infringement claim. A justice
system works best when everyone has equal access to information about their
legal rights and responsibilities, as well as qualified and well-informed counsel.
This article makes three key contributions to the scholarly literature in the
field of agricultural biotechnology patent infringement. First, it exposes a new
and largely unrecognized problem pertaining to the legal remedy of accounting
of profits for patent infringement. To address this problem, the article corrects
misunderstandings about recent court decisions pertaining to the accounting of
profits remedy. Second, the article critically examines the discourse used to dis-
cuss accounting of profits, which includes sometimes inconsistent concepts,
terms, and definitions. The article proposes strategies to facilitate definitional
and conceptual coherence in order to establish a framework for future jurispru-
dence and scholarship on this topic. Finally, the article provides insights into
the unsustainability of current trends in this area of law.
17. "The Parable of the Sower" The Economist (19 November 2009), online: <http://
www.economist.com/displaystory.cfm?story-id= 14904184>.
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To achieve these goals, the article focuses solely on remedies and does not
discuss the validity of agricultural biotechnology patents. The article begins
with a background on patented technology and enforcement strategies, followed
by a discussion of the infringement remedies granted in recent cases. These cases
are then situated within the broader legal framework for, and the discourse re-
lated to, patent infringement remedies, while highlighting the special considera-
tions that apply in the agricultural biotechnology context. The article concludes
with a summary, analytical insights, and considerations for going forward.
I. AGRICULTURAL BIOTECHNOLOGY PATENTS AND
ENFORCEMENT STRATEGIES
There are many conflicting opinions on the effects of genetically modified crops
on agribusiness. Few people would disagree that biotechnology has contributed
to radical changes in how farmers conduct business. The changes range from
how growers manage their crops, land, and pesticide programs to how they buy
and save seeds for planting from year to year. Since the proliferation of geneti-
cally modified crops, seed saving has triggered particular legal challenges."
The Monsanto Company of St. Louis, Missouri and its Canadian subsidi-
ary, Monsanto Canada Inc.,19 are leaders in agricultural biotechnology devel-
opment, marketing, and sales. Monsanto sells several genetically modified seed
varieties, including its Roundup Ready brands. Roundup Ready seed has been
marketed by Monsanto since 199620 for a variety of crops, including soybeans,
canola, corn, and cotton.
Seeds containing Roundup Ready technology grow into plants that are tol-
erant to glyphosate-based herbicides. Roundup Ready plants are desirable be-
cause they permit growers to spray fields with glyphosate-based herbicides to
kill weeds without harming the glyphosate-tolerant crop. This trait has been
very lucrative. 1
18. See Jeremy de Beer, "Reconciling Property Rights in Plants" (2005) 8 J. World Intell.
Prop. 5 at 9.
19. For the purposes of this article, Monsanto Company and Monsanto Canada Inc. are
collectively referred to as "Monsanto."
20. Monsanto Canada, "Company History," online: <http://www.monsanto.com/who weare/
history.asp>.
21. Monsanto Canada, News Release, "Monsanto Biotechnology Trait Acreage: Fiscal Years
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Legal use of Roundup Ready technology requires growers to sign a Tech-
nology Use Agreement (TUA) and pay a licensing fee to Monsanto.22 Contracts
prohibit the traditional farming practice of saving and replanting harvested
seeds. Farmers who licence the technology, therefore, have recurring seed pur-
chase costs that generate revenues for the licensor every growing season. Rely-
ing on contracts alone to support this business model is inadequate, however;
third parties who have never purchased Monsanto seed are not bound by
Monsanto's terms and conditions. Monsanto, therefore, relies on patent pro-
tection to prevent these farmers from acquiring and growing Roundup Ready
crops.
Prior to the Supreme Court's decision in Schmeiser, it was not certain
whether genetically modified crops were patentable subject matter under the
Patent Act.23 In an earlier decision, Harvard College v. Canada (Commissioner of
Patents), it was held that higher life forms, specifically plants and seeds, are not
patentable." The Supreme Court of Canada has also highlighted, in Pioneer Hi-
Bred Ltd. v. Canada (Commissioner of Patents), that patenting plant crossbreed-
ing is problematic.25
Unlike the patent claims at issue in Harvard Mouse, however, Monsanto's
patent did not claim an entire higher life form. Instead, its claims were lim-
ited to the specific genes and cells within seeds and plants that provide gly-
phosate-based herbicide resistance.2 In Schmeiser, the Supreme Court of Canada
concluded that genes and cells are not higher life forms and are patentable.27
In addition, unlike the failed patent application in Pioneer Hi-Bred, Mon-
1996 to 2007" (10 October 2007), online: <http://www.monsanto.com/pdf/investors/2007/
FY2007BiotechAcre.pdf>. In 2007, 67.4 million acres of Roundup Ready corn, 61.2
million acres of Roundup Ready soybeans, and 8.6 million acres of Roundup Ready cotton
was grown in the United States, while 6.8 million acres of Roundup Ready canola was grown
in Canada.
22. For an example of a Monsanto Technology Use Agreement, see Monsanto Canada,
"Genuity- Roundup Ready ® Canola Technology Use Agreement," online:
<http://www.monsanto.ca/seeds-traits/tua/default.asp>.
23. R.S.C. 1985, c. P-4.
24. [2002] 4 S.C.R. 45 at para. 206 [Harvard Mouse].
25. [19891 1 S.C.R. 1623 at para. 30.
26. Schmeiser (2004), supra note 6 at paras. 129-3 1.
27. Ibid. at para. 22.
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santo's application sufficiently disclosed the invention.28 The Supreme Court,
therefore, validated Monsanto's patent for glyphosate-resistant plants.
29
The Court also held that Schmeiser infringed Monsanto's patent, contrary
to section 42 of the PatentAct,' by planting saved seeds, which constitutes use
of the patent technology.31 Consequentially, saving and planting seeds contain-
ing patented cells and genes is considered infringement of a patent, and any
farmer who does so breaks the law.32
Monsanto vigorously enforces its patents, explaining that its actions "keep
the playing field level for all growers."33 Its Seed Piracy newsletter warns farmers
that infringers face penalties of up to $200 an acre, and identifies counties in
Canada where a "sizable number" of infringers have been caught." Critics con-
tend that Monsanto is engaged in "ruthless legal battles against small farmers,"
among whom it strikes fear with a "shadowy army of private investigators and
agents," and disrupts the millennia-old practice of saving seeds from one season
to the next.3" Furthermore, allegations persist that Monsanto aggressively
pushes for ever-higher settlements, which in turn are held out as precedents to
achieve even higher future settlements.36
28. Ibid. at paras. 15-16.
29. Ibid. at para. 24. See also Schmeiser (2003), supra note 9 at para. 46; Monsanto Caiada Inc. v.
Schmeiser (2001), 202 F.T.R. 78 at para. 90 (F.C.T.D.) [Schmeiser (2001)].
30. Supra note 23, s. 42.
31. Schmeiser (2004), supra note 6 at paras. 26-27. See also Schmeiser (2003), supra note 9 at
para. 60; Schmeiser (2001), supra note 29 at para. 127.
32. Schmeiser (2004), ibid. at para. 97.
33. Pratt, supra note 1 at para. 47.
34. Hyland Seeds, "Seed Piracy: Updates and Summaries" (March 2007), online: <http://
www.hylandseeds.com/products/Seed%20Piracy%20newsletter/020-%20March%202007
%20-%20English.pdf>. See also Jeffrey Carter, "Monsanto Goes After Biotech Crop Patent
Violators" Ontario Farmer (4 April 2006).
35. Donald L. Barlett & James B. Steele, "Monsanto's Harvest of Fear" Vanity Fair (May 2008),
online: <http://www.vanityfair.com/politics/features/2008/05/monsanto200805>. See also
Armen Keteyian, "Agricultural Giant Battles Small Farmers" CBS Evening News (26 April
2008), online: <http://www.cbsnews.com/stories/2008/04/26/eveningnews/main4048288.
shtml>; Andrew Kimbrell & Joseph Mendelson, Monsanto vs. US. Farmers: A Report by the
Center for Food Safety (Washington: Center for Food Safety, 2005), online: <http://www.
centerforfoodsafety.org/pubs/CFSMOnsantovsFarmerReportl .1 3.05.pdf>.
36. Carter, supra note 34.
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II. RECENT AGRICULTURAL BIOTECHNOLOGY
PATENT CASES
Since Monsanto first marketed Roundup Ready crops, the company has
reached out-of-court settlements with more than one hundred growers in Can-
ada.17 As of August 2009, Monsanto had filed ten lawsuits against alleged in-
fringers. Six proceeded to trial, of which three-Scmeiser, Rivett, and
Janssens-resulted in a judgment on their merits. Four-Monsanto Canada Inc.
& Monsanto Company v. James Elmer Murray et al.,38 Monsanto Canada Inc. et.
al. v. Tee Chase Enterprises Inc. et al.," Monsanto Canada Inc. et aL v. Erwin
Deck," and Monsanto Canada Inc. &Monsanto Company v. Sheldon Chamberlin
et aL4 -were discontinued, presumably due to out-of-court settlements.
A. Monsanto Canada Inc. v. Schmeiser
In 2001, the Trial Division of the Federal Court ruled that Monsanto's gly-
phosate-resistant patent was valid and that Percy Schmeiser infringed that pat-
ent by growing 950 acres of glyphosate-resistant canola in 1998. The court
considered the following claims for relief: "[A]n injunction; delivery up of any
canola remaining from Schmeiser's 1998 crop; profits of $105,000 for Mon-
santo US; damages of $15,450 for Monsanto Canada; exemplary damages of
$25,000 and pre-judgment and post-judgment interest."2
Because Schmeiser did not act "in a manner that would warrant punish-
ment or that would deserve condemnation by the court,""3 exemplary damages
were denied. The trial judge granted the injunction and delivery up requests,
however. He refused Monsanto's request for both an accounting of profits and
compensatory damages, instead awarding only profits."
37. Pratt, supra note 1. As of the end of 2007, Monsanto had reached out-of-court settlements
with 109 growers.
38. (12 August 2009), Winnipeg T-1362-08 (F.C.T.D.).
39. (27 July 2007), Winnipeg T-1525-05 (F.C.T.D.).
40. (11 October 2006), Saskatoon T-1704-04 (F.C.T.D.).
41. (3 February 2003), Edmonton T-1459-02 (F.C.T.D.).
42. Schmeiser (2001), supra note 29 at para. 128.
43. Ibid. at para. 141, citing Lubrizol Corp. v. Imperial Oil Ltd (1996), 67 C.P.R. (3d) 1 at 18
(F.C.A.) [Lubrizol (1996)].
44. Ibid. at para. 140.
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Failing agreement on a figure representing profits, Monsanto would have
been granted general damages, plus any additional established damages."5 Two
aspects of the trial decision were particularly important for the accounting of
profits remedy. First, the judge rejected Schmeiser's argument that "there were
no measurable profits earned" because "the defendants would have earned the
same profits on sale of a canola crop that did not contain the gene."" Second,
he expressly declared that Schmeiser's unpaid labour should be recognized as a
deduction in accounting for profits." The trial judge determined that the
monetary award should equal no more than the profit from the sale of
Schmeiser's 1998 canola crop, which was assessed at $19,832.8 This figure was
derived from the financial records of Schmeiser's accounting expert witness,
who attributed a net profit of $35,034 to his crop, 9 minus an allowance of
$15,202 for Schmeiser's labour. Another element of the assessment of deduc-
tions appears to be indirect fixed expenses, including those referred to as "ac-
counting," "insurance," "depreciation, ""5 and others, which were apportioned
relative to the acreage of the infringing canola. Both parties appealed to the
Federal Court of Appeal.
Like the trial judge, the appellate court rejected Schmeiser's claim that, be-
cause "he realized no financial benefit" from the patent, he should not have to
account for profits associated with the crop containing the patented technology."'
It also dismissed Monsanto's appeal that the award was too high and cross-appeal
that the award was too low. Accounting for profits is "fundamentally an equita-
ble remedy" and, as such, the quantum may be adjusted on a "principled basis,"5
which permitted Schmeiser's labour to be deductible. Both parties appealed to
the Supreme Court of Canada, alleging, among other things, remedial errors.
The Supreme Court of Canada affirmed the trial and appellate rulings re-
garding patent infringement, but, unlike the Federal Court of Appeal, the Su-
45. Ibid.
46. Ibid. at para. 135.
47. Ibid. at para. 137.
48. Schmeiser (2003), supra note 9 at para. 74.
49. Schmeiser (2001), supra note 29 (Evidence, exhibit D-150). [Schmeiser Financial Records].
50. Ibid.
51. Schmeiser (2003), supra note 9 at paras. 78-80.
52. Ibid.
DE BEER & ANDREWS, BIOTECHNOLOGY PATENT INFRINGEMENT 629
preme Court adjusted the remedy awarded by the Trial Division. The quantum
of the award was reduced to zero, based on the argument that Schmeiser "made
no profits as a result of the invention." 3 The Supreme Court concluded that
Schmeiser did not benefit from the invention because he did not sell the crop at
a premium price as Roundup Ready. Schmeiser did not spray the crop with a
glyphosate-based herbicide. 6 His yield, therefore, did not increase, nor were his
costs reduced, by the seeds' herbicide resistance.
But what would happen if an infringer did use glyphosate-based herbicide,
thus benefiting from the patent's utility? The Supreme Court's decision sug-
gests that a patentee should only be entitled to the infringer's profits enjoyed as
a result of infringement. Whether or not an infringer is liable to a patentee only
for the difference between profits earned as a result of infringement and profits
that would have been earned using a non-infringing alternative was an unan-
swered question between 2004 and 2009-a period when Monsanto settled
most disputes without a trial, or, in many cases, even a lawsuit.
B. Monsanto Canada Inc. v. Mazurkewich
In March 2006, Monsanto Canada Inc. v. Mazurkewich became the first Ca-
nadian agricultural biotechnology patent infringement case to be delivered
since Schmeiser5 The consent judgment in this case awarded Monsanto
$80,279, with no costs, as a result of the defendant planting approximately
2000 acres of Roundup Ready canola without a licence. The award equalled
roughly $40 per acre.
Mazurkewich reached the courts because the defendant breached the terms
of a settlement agreement with Monsanto. Terms of the settlement had in-
cluded $30,000 in monetary compensation to Monsanto and an additional un-
dertaking to buy $70,000 worth of Monsanto products within approximately
two years.56 It is worth noting that the settlement, after subtracting the prom-
ises to purchase Monsanto products, amounted to approximately $15 per acre
(roughly the ordinary licence fee for Roundup Ready seed).
53. Schmeiser (2004), supra note 6 at para. 103 [emphasis in original].
54. Ibid. at paras. 102-04.
55. (20 March 2006), Edmonton T-1325-02 (F.C.T.D.).
56. Ibid.
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C. Monsanto Canada Inc. v. Wouters
In June 2007, the Federal Court Trial Division made the richest award of
any agricultural biotechnology patent case tried in Canada. The defendant in
Wouters was ordered to pay Monsanto over $97,000, plus $10,000 in costs,
for planting 393 acres of Roundup Ready soybeans without signing an
agreement or paying the requisite licensing fees. 7 This award represented
Wouters' supposed profits and equalled approximately $274 per acre (the
award without costs included was, perhaps confusingly, about $247 per acre).
The outcome was triumphantly publicized by Monsanto, suggesting that it
should be considered a precedent-setting case in the wake of Schmeiser."8
Wouters, however, was a default judgment resulting from an inadequate,
almost non-existent defence.5" The judge's reasons did not include meaningful
analysis and, as such, provide little or no jurisprudential guidance. Nevertheless,
it is worth reviewing the case to demonstrate the seriousness of patent infringe-
ment litigation and the need for appropriate representation.
Monsanto elected to seek an accounting of profits, rather than damages, as
a remedy for patent infringement in the case. This put the onus on Monsanto
to establish (through examination for discovery and other evidence gathering)
Wouters' gross revenues. Wouters was then entitled to prove allowable deduc-
tions for expenses in order to assess the net profits to be disgorged.
Court records show that Wouters initially retained a lawyer, but that the
relationship did not last for unspecified reasons. Wouters was self-represented
during key phases of the litigation process. Without a lawyer, he repeatedly de-
faulted on his obligations to the court. Most notably he did not respond to
Monsanto's "requests to admit," which then deemed him to have admitted all
of the facts necessary to establish an infringement.6" Wouters also did not pro-
duce a sworn affidavit of documents, which might have provided the court with
a "principled basis" to assess deductible expenses.61 Monsanto's lawyers repeat-
57. Wouters, supra note 4 at para. 4.
58. Pratt, supra note 1. See also Monsanto Canada, News Release, "Ontario Grower Ordered to
Pay Monsanto $107,000 for Violating Patent Rights on Roundup Readyo Soybeans" (25
June 2007), online: <http://www.monsanto.calabout/news/2007/06_25-07.asp> [Monsanto
v. Wouters, News Release].
59. Wouters, supra note 4 at para. 5.
60. Ibid.
61. Ibid. at para. 6.
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edly encouraged Wouters to find legal counsel. At one point, Wouters even an-
nounced to the court and opposing counsel that he intended to have Percy
Schmeiser represent him. This proposal was promptly refused given that Mr.
Schmeiser is not a lawyer. Wouters did eventually retain another lawyer to rep-
resent him, but not until shortly before a motion to have the defence struck. At
the hearing of that motion, no one appeared on Wouters' behalf.62
Monsanto's motion was granted and the defence was struck out. The court
found in favour of Monsanto on the question of infringement, and the company
was awarded Wouters' estimated profits. The court could only estimate profits be-
cause there was no evidence to account for revenues or costs of production.63 To
estimate yields and income, the court adopted Monsanto's proposal to take the
average county yields and crop prices from the website of the Ontario Ministry of
Agriculture, Food and Rural Affairs (OMAFRA)6" and subtract the few expense
receipts Wouters had disclosed to Monsanto in an un-sworn affidavit of docu-
ments.65 Because no evidence was tendered to compare the profits of the infringing
crop in relation to the best non-infringing alternative, the court had no opportu-
nity to tailor the award to reflect the benefit provided by the infringing crop.
Given the circumstances, the amount awarded to Monsanto was, in es-
sence, Wouters' gross revenues. The award was undoubtedly disproportionate
to the actual net profits (or Wouters had, by far, the most profitable soybean
crop ever), but has nevertheless been touted publicly as a warning to deter other
would-be patent infringers.
D. Monsanto Canada Inc. v. Beneteau
In November 2007, the Beneteau decision resulted in an order for the defen-
dant to pay Monsanto a lump sum of $8,800 for growing and harvesting 55
acres of soybeans containing Monsanto's patented technology. Because court
62. Ibid. at Oara. 2.
63. Ibid. at para. 3.
64. Ibid. (Evidence, Monsanto's Affidavit of Documents) [Monsanto v. Wouters, Affidavit of
Documents]. See also Agricorp and Statistics Canada (Field Crop Reporting Series),
"Soybeans: Area and Production, Ontario by County, 2004," online: <http://www.
omafra.gov.on.ca/english/stats/crops/ctysoy04.htm>; Bill McGee, "Soybeans - Prices,
Ontario, 1981-2008," online: <http://www.omafra.gov.on.ca/english/stats/crops/price-
soybean.htm>.
65. Monsanto v. Wouters, Affidavit of Documents, ibid.
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documents do not provide any hints regarding the rationale behind the agreed
amount, the case provides no guidance for analyzing legal remedies in biotech-
nology patent infringement cases. Yet, as with Wouters, the per acre result was
highly publicized. The fact that Beneteau was a consent judgment was not ac-
knowledged. While some newspapers reported the total award," headlines pro-
claimed damages of $160 per acre. This per acre amount is a daunting sum
when multiplied by the large acreages typical of most farmers. Given that the
total amount owing to Monsanto was relatively small (being less than what
might be expected for costs alone if it had proceeded to trial), however, it is un-
surprising that the case settled.
E. Monsanto Canada Inc. v. Rivettand Monsanto Canada Inc. v. Janssens
In January 2009, the cases of Rivett and Janssens were both heard before Justice
Russel Zinn of the Federal Court. Although the two cases were technically tried
separately, counsel for the parties were the same in both, arguments from coun-
sel were basically the same, and the two cases were heard back-to-back. Not
surprisingly, the decisions were consistent. The reasons in the Janssens deci-
sion frequently reference Rivett, which provided a more detailed analysis.
It is interesting to note that, even though Monsanto filed its claim
against Wouters at the same time it filed against Rivett, the awards granted in
the two actions are very different. The Wouters award was almost six times
larger, per acre, than the award in Rivett, certainly because of the involvement
of legal counsel.
The defendants in Rivett and Janssens did not contest the validity of Mon-
santo's patent,67 nor the fact that they infringed it by growing Roundup Ready
soybeans without signing a TUA or paying licensing fees.68 Rivett grew 947 acres
in 2004,69 and the multiple defendants in Janssens collectively grew a combined
300 acres in 2004 and 2005."0 The defendants also admitted to spraying crops
with glyphosate-based herbicide and benefiting from the patented invention.
66. Canada News Services, "Monsanto Wins Patent Violation Case" The Star Phoenix (12
December 2007), online: <http://www.canada.com/saskatoonstarphoenix/news/national/
story.html?id=fc2b7311-4758-44b9-ab85-ddd6766928e2>.
67. Rivett, supra note 11 at para. 11; Janssens, supra note 12 at para. 8.
68. Rivett, ibid. at para. 7; Janssens, ibid. at para.. 12.
69. Rivett, ibid. at para. 11.
70. Janssens, supra note 12 at paras. 8, 13-15.
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In both cases, Monsanto sought accounting of profits as a remedy. With
the question of infringement established, and the remedy elected by the plain-
tiff, the main issue to be determined was the appropriate amount of profits, if
any, to be disgorged by the defendants. Each defendant testified about details
related to the expenses that they had incurred. A Monsanto executive testified
about the benefits of Roundup Ready seeds and the additional profit the defen-
dants might generate. 1 Notably, one individual who did not testify was the de-
fendants' proposed accounting expert witness; his evidence as an expert was
inadmissible for technical reasons. The expert's statement was not of the proper
form, nor was it served on the plaintiffs on time.7" Had he been allowed to tes-
tify, he would have presented evidence regarding the costs and benefits attribut-
able to Roundup Ready soybeans.73 Through admissible evidence, in the form
of individually submitted exhibits, the defendants were able to provide the
court with a number of receipts and other evidence of legitimate deductible ex-
penses. The defendants did not, however, offer any evidence to question the net
financial benefits attributable to Roundup Ready soybean seed production.
Given the evidence, the court considered legal issues regarding the proper
method for conducting an accounting of profits, the allowable deductions for
expenses, and the final calculation of profits to be disgorged.7" Monsanto ar-
gued that only direct costs attributable to the infringement should be deducti-
ble from gross revenues in determining profits to be awarded, and that it is
inappropriate to consider what profits might have been without the infringe-
ment.7" In support of this position, the plaintiff relied on "what is claimed to be
30 years of jurisprudence,"76 as well as a recent case commentary by D.A. Aylen
and M.J. Graff." Monsanto and the authors of the commentary posited that if
the Supreme Court had intended to overrule thirty years of precedent, it would
have addressed the issue and corresponding case law more explicitly: "That the
71. Rivet, supra note 11 at para. 12.
72. His evidence was disallowed pursuant to the Federal Court Rules, S.O.R./1998-106, s. 279.
73. Rivett, supra note 11 at para. 13; Janssens, supra note 12 at para. 23.
74. Rivetn, ibid. at para. 17; Janssens, ibid. at para. 24.
75. Rivett, ibid. at paras. 30, 34.
76. Ibid. at para. 42.
77. D.A. Aylen & M.J. Graff, "The 'Differential Profit' Approach in Monsanto" in Return of the
Six Minute Intellectual Property Law Lawyer (Law Society of Upper Canada, Continuing
Legal Education, Toronto, 10 November 2004) Tab 21 at 5-7.
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court did not do so ... supports the position that the court was addressing the
equity demanded in the particular facts in Schmeiser."78 Justice Zinn disagreed
and, like the Supreme Court, adopted an approach that "looks to those profits
that result from the invention that is protected and eliminates those profits that
may be earned but that have no causal link to the invention." 9
The analysis then shifted to the second issue: determining which expenses
could be properly deducted from the gross revenues attributable to the sale of
infringing soybeans. The court allowed deductions for the costs of fertilizer,
land rent, fuel, herbicide, inoculants, carbon, and crop insurance,80 even though
the defendants could not directly correlate all of the expenses to the infringing
crop. There was little doubt that these costs were incurred in the course of in-
fringement. Rivett, for example, could show total farm operating expenses at-
tributable to his entire 3,516-acre farm, but could not precisely identify how
much of each expense was attributable to the 947 acres of infringing crop. The
court, approaching the profits assessment on a principled basis, permitted an
apportionment of these expenses based on the percentage of infringing acres,
which was determined to be 26.9 per cent of the farming operation."
Where the defendants did not offer any evidence related to a given expense,
even if it was clear that the expense was incurred and could have been deducti-
ble, it was disallowed. For example, Rivett could not provide receipts for all the
land he rented, so there was no basis to allow this particular deduction.82 In
Janssens, the court permitted no deductions for the 2004 infringing crop be-
cause there was no evidence pertaining to that crop, despite pleadings that
"soybeans do not plant, cultivate and harvest themselves,"83 and that the 2005
crop expenses should be comparable. Property tax deductions were also disal-
lowed because the defendants provided no evidence in this regard." '
In addition to listing permissible deductions, the court commented on a
number of expenses that should not normally be deductible. In Rivett, the court
78. Rivett, supra note 11 at para. 44.
79. Ibid. at para. 53.
80. Ibid. at paras. 70-93; Janssens, supra note 12 at paras. 35-41.
81. Rivett, ibid. at para. 68.
82. Ibid. at paras. 80-8 1. Determining an amount for land rent was further complicated by the
fact that Rivett exchanged farm services and hay for some of the land rent.
83. Janssens, supra note 12 at para. 33.
84. Ibid. at para. 52.
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expressly rejected costs such as "general farm insurances, capital depreciation,
water, electricity, etc." as "too indirect.""5 The court also rejected submissions
by the defendants in Janssens that deductions should be allowed to reflect ser-
vices performed by the defendants, such as "harvesting, trucking, spraying,
[and] marketing"86 the infringing crop. The court felt that it would be too diffi-
cult to disentangle labour costs and profits normally figured into custom rates
charged by third parties.8" A deduction for the defendant's own labour was de-
nied in both Rivett and Janssens.88
The kinds of deductions denied in Rivett and Janssens were allowed in
Schmeiser, including general insurance, depreciation, accounting, and labour
costs.89 The table in Appendix A summarizes various allowable or disallowable
deductions in these cases.
After determining deductible expenses, the remaining question was: what
profits were attributable to the infringement? The only admissible evidence on
this point came from testimony for Monsanto indicating the relative profitabil-
ity of Roundup Ready crops compared to conventional crops, through increased
yield and lower costs of production." While Monsanto's evidence showed a dif-
ference in profitability of roughly 18 per cent, the court adjusted the figure, in
Monsanto's favour, to 31 per cent because infringers paid nothing for their
seed. This adjustment effectively compared the profitability of Roundup Ready
soybeans from free seed with the profitability of conventional soybeans from
bought seed. By implication, the court discounted the defendants' actual net
profits by 69 per cent to represent the profits that would have been earned us-
ing the best non-infringing option.
In the end, the court in Rivett calculated the damages award at $40,138, or
$42 per acre.9 The defendants in Janssens were ordered to disgorge a total of
$14,538 between them, for both years of infringement, amounting on average
85. Rivett, supra note 11 at para. 69.
86. Janssens, supra 12 at para. 42.
87. Ibid. at para. 43.
88. Rivert, supra note 11 at paras. 90-92; Janssens, ibid. at para. 43.
89. Schmeiser Financial Records, supra note 49; Schmeiser (2003), supra note 9 at para. 87.
90. Rivett, supra note 11 at paras. 100-01.
91. Ibid. at para. 102.
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to $48 per acre,92 plus legal costs and interest. The tables in Appendix B pro-
vide a detailed financial breakdown of these awards.
III. REMEDIES IN GENERAL CONTEXT
The foregoing discussion of recent case law may lead some people to believe that
the difficulties in this area of the law are mainly mathematical. To the contrary,
there are deep conceptual problems, information asymmetries among plaintiffs'
and defendants' counsel, quirky fact patterns, and seemingly ad hoc decision
making in many patent infringement remedies cases. To understand fully the
nature of the problem and to begin to explore possible solutions, it is necessary
to put the remedy of accounting of profits in agricultural biotechnology patent
infringement cases in a broader context.
Relief sometimes granted in Canadian patent infringement cases can include:
general damages, punitive damages, accounting of profits, injunctions, and/or
orders to deliver-up infringing goods.93 Although injunctions and delivery-up
orders are important remedies, this article focuses on the monetary remedies of
general damages, punitive damages, and, more specifically, accounting of profits.
A. General Compensatory Damages
The Patent Act provides a patent holder with a right to damages for losses suf-
fered from a proven 'patent infringement." The aim of such an award is "to
compensate the plaintiff for any losses suffered by the plaintiff as a result of the
infringement"9" and to put the patent holder back into the position that he or
she would have been in had the infringement not occurred.96 Although courts
have stated that "damages should be liberally assessed," a damage award is still
limited by "that which a plaintiff may lawfully prove."97
92. Janssens, supra note 12 at para. 51.
93. See generally Daniel Gervais & Elizabeth F. Judge, Intellectual Property: The Law in Canada
(Toronto: Thompson Canada, 2005) at 475.
94. Patent Act, supra note 23, s. 55.
95. BayerAktiengesellschafi v. Apotex Inc. (2001), 10 C.P.R. (4th) 151 (Ont. Sup. Ct.) at para. 12
[Bayer]; See also Beloit Canada Ltd. v. Valmet-Dominion Inc., [1997] 3 F.C. 497 (F.C.A.)
[Beloit (1997)1.
96. (1998), 142 F.T.R 241 at para. 19 (F.C.T.D.) [AlliedSignal(1998)].
97. Unilever PLCv. Procter & Gamble Inc. (1995), 98 F.T.R. 80 at para. 47 (F.C.A.).
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Courts will consider various means to assess damages in patent cases. Gen-
erally, damage awards represent lost sales in the form of profits a patentee
would have made but for the infringement. If a patentee's revenue stream hap-
pens to come from licences to use the patent, then damages will generally be
based on lost royalties.98 This principle was stated in AlliedSignal Inc. v. Du
Pont Canada Inc.: "Where the patentee has licensed its invention in the past, it
is 'almost a rule of law' to assess damages in terms of a reasonable royalty; i.e.,
according to what the infringer would have paid if it had entered into a legiti-
mate licensing agreement with the patentee."99
Because agricultural biotechnology licensing fees are a standard rate, calculat-
ing damages in patent infringement cases should be straightforward. A damage
award merely covering lost royalties, however, is unappealing to patent owners,
mainly because it provides little or no potential deterrent to future infringers.
B. Punitive Damages
Punitive damages are not compensatory in nature. Their goals are to punish a de-
fendant, to express "outrage at the egregious conduct,"' and to "act as a deterrent
to the defendant and to others from acting in this manner.' 1 They are generally
reserved for situations where they will "serve a rational purpose,"1"2 and where
compensatory damages "would be insufficient to achieve the goal of punishment
and deterrence."0 3 This requires "high-handed, malicious, arbitrary or highly rep-
rehensible conduct that departs to a marked degree from ordinary standards of de-
cent behaviour...... The general test is: "[W]as the misconduct of the defendant so
outrageous that punitive damages were rationally required to act as deterrence?"0 5
98. Franqois M. Grenier & Alexandra Steele, "Litigation Procedures and Remedies" in Donald
M. Cameron, Chair, Intellectual Property Law Primer: Focus on Patent Law (Law Society of
Upper Canada, Donald Lamont Learning Centre, 18 September 2007) Tab 9 at 40-41.
99. AlliedSignal (1998), supra note 96 at para. 22. See also Meters Ltd. v. Metropolitan Gas Meters
Ltd. (1911), 28 R.P.C. 157 at para. 164 (C.A.); Catnic Components Ltd. v. Hill & Smith Ltd.
(1982), R.P.C. 183 (H.L.).
100. Hillv. Church of Scientology of Toronto, [1995] 2 S.C.R. 1130 at para. 196 [Hill].
101. Ibid. at para. 196.
102. Ibid. at para. 197.
103. Ibid. at para. 196.
104. Whiten v. Pilot Insurance Co., [2002] 1 S.C.R. 595 at para. 94.
105. Ibid. at para. 100.
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Canadian courts have been careful to not award punitive damages liberally.
Requests for such awards should be subject to "careful consideration," and the
courts' discretion to award them should be "cautiously exercised."'' 6 If a court
finds punitive damages to be warranted, the quantum should not be excessive,
but, rather, in keeping with the "Canadian experience" of "relatively modest"
punitive damage awards.'
Although rare, punitive damages are available in Canadian patent in-
fringement cases.0 8 A court may grant such a remedy where the state of mind
of the defendant is callous, reprehensible, vindictive, or outrageous." 9 Cir-
cumstances that have led Canadian courts to grant punitive damages in pat-
ent infringement cases include a wilful breach of an injunction,"0 litigation
misconduct, or abuse of process."' In patent infringement cases, as in other
cases, the purpose of awarding punitive damages is both to punish the defen-
dant for wrongdoing and to deter others from engaging in similar conduct."2
Although deterrence is a factor in determining the appropriateness of puni-
tive damages, Canadian courts are not inclined to provide such a remedy in
cases where the only rationale for awarding punitive damages is the intentional
infringement of a patent. In Dimplex North America Ltd. v. CFM Corp., the
judge stated: "There are no patent cases in the Federal Court that I am aware of
where punitive damages have been awarded simply because the defendant
knowingly or intentionally infringed the patent without more.""' 3
This position was later affirmed in Wi-Lan Technologies Corp. v. D-Link
Systems Inc., where the court held that, despite "callously, knowingly and wil-
106. Vorvis v. Insurance Corporation of British Columbia, [1989] 1 S.C.R. 1085 at para. 24.
107. Ibid. at para. 62.
108. Lubrizol(1996), supra note 43 at paras. 33, 41.
109. Ibid. at paras. 38, 40.
110. Ibid. at para. 38; Apotex Inc. v. Merck 6- Co. (2002), 219 F.T.R. 259 at paras. 41, 45
(F.C.T.D.).
111. In a recent case involving copyright infringement, for example, punitive damages were
awarded where there was infringement, a cease-and-desist letter was ignored, and the
defendant expressed a preference to pay legal fees rather than abide by the law. See Profekta
International Inc. v. Lee (c.o.b. Fortune Book & Gift Store) (1997), 75 C.P.R. (3d) 369 at
para. 6 (F.C.A.).
112. Hill, supra note 100 at paras. 195-203.
113. (2006), 292 F.T.R. 38 at para. 123 (F.C.).
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fully" infringing the plaintiffs patent, the defendant's conduct failed to consti-
tute "misconduct that represents a marked departure from ordinary standards
of decent behaviour. '11 Short of facts that demonstrate "abuse, fraud, malice,
contract, fiduciary obligation, agency, or the like," the court advised that there
should be no definitive conclusion warranting punitive damages."' It has also
been acknowledged that ignoring cease-and-desist threats from plaintiffs coun-
sel will not warrant punitive damages. " 6
Canadian courts' cautious approach to punitive damages has been consistent
in agricultural biotechnology patent infringement cases. In response to Mon-
santo's claims for punitive damages at trial in the Schmeiser case, for e.g., the court
determined that Schmeiser did not act in a manner that would "warrant punish-
ment" or "condemnation by the court," ' 7 regardless of his actual or imputed
knowledge that he was using the company's patented technology. Since Schmeiser,
Monsanto has reduced efforts to obtain punitive damages from infringing farmers.
Although it initially claimed punitive damages in the Rivett and Janssens cases, by
the time these cases went to trial, Monsanto dropped those claims, citing Dimplex
as the reason.
In contrast, punitive damages have been readily awarded by US courts in
agricultural biotechnology patent infringement cases. In the United States, in-
tentional and wilful infringement could result in a tripling of damage awards.
To date, Monsanto has filed over a hundred lawsuits against farmers and small
farm businesses in the United States (compared to only ten lawsuits filed in
Canada). Approximately half of these lawsuits have ended with damage
amounts totalling over US $21,000,000 (compared to just over $240,000 in
Canada). The largest US award is over $3,000,000 (compared to $97,000 in
Canada), while the average has been about US $400,000."'
114. (2006), 57 C.P.R. (4th) 1 at para. 7 (F.C.).
115. Ibid. at para. 10.
116. Jay-Lor International v. Penta Farm Systems Ltd. (2007), 59 C.P.R. (4th) 228 at para. 257
(F.C.) [Jay-Lorl.
117. Schmeiser (2001), supra note 29 at para. 141.
118. For the source of these US statistics, see Center for Food Safety, Bulletin, "Monsanto vs.
U.S. Farmers: November 2007 Update," online: Center for Food Safety <http://
truefoodnow.files.wordpress.com/2009/12/monsanto20november20200720update.pdf>.
Canadian statistics are current up to August 2009.
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Arguably, the American approach to punitive damages provides a more ef-
fective deterrent against infringement. If damages are elected, the prospect for a
large award is greater in the United States than it is in Canada. It is important
to point out that an accounting of profits remedy is not available in the United
States as it is in Canada. Since 1946, an infringer's profits have not been recov-
erable for infringement of a utility patent in the United States. 19 It may be ar-
gued that providing for an accounting of profits, which has the potential to
generate large awards, is Canada's way of deterring infringement.
C. Accounting of Profits
Damages compensate a plaintiff for direct losses suffered as a result of infringing
activity, or serve to punish infringers and deter future infringements. An account-
ing of profits, however, awards to a plaintiff the profits improperly earned by a
defendant as a result of infringement. The objective is not to punish the in-
fringer (though the infringer may be deterred), nor to compensate the plaintiff,
but, rather, to remedy the defendant's unjust enrichment by transferring profits
to the patent owner.12 The principle was explained in one case as follows:
An accounting of profits ... aims to disgorge any profits improperly received by
the defendant as a result of its wrongful use of the plaintiffs property. Such prof-
its, having been earned through the use of the plaintiffs property, rightly belong
to the plaintiff. The aim is to remedy the unjust enrichment of the defendant by
transferring these profits to their rightful owner.
121
The Supreme Court in Strother v. 3464920 Canada Inc. 22 described the pur-
pose of the disgorgement of profits remedy to be either or both "prophylactic"
and "restitutionary." As pointed out in Rivett. "[I]f one assumes that the motive
for the infringement is profit, then ordering a wrong-doer to hand over those
119. See J. Thomas McCarthy, McCarthy's Desk Encyclopedia of Intellectual Property (Washington:
BNA Books, 1991) at 246.
120. Reading &Bates Construction v. Baker Energy Resources Corp., [1995] 1 F.C. 483 at para. 12
(F.C.A.) [Reading & Bates]. See also Teledyne Industries v. Lido Industrial Products Ltd.
(1982), 68 C.P.R. (2d) 204 (F.C.T.D.) [Teledyne]; Beloit Canada Ltd. v. Valmet Oy (1994),
78 F.T.R. 86 at para. 71 (F.C.T.D.) [Beloit (1994)] , var'd on other grounds (1995),
A.C.W.S. (3d) 1252; Lubrizol (1996), supra note 43 at paras. 37, 41; and Bayer, supra note
95 at para. 12.
121. Bayer, ibid., citing Beloit (1994), ibid. at para. 130.
122. [2007] 2 S.C.R. 177 at paras. 75-76.
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profits to the person who has been wronged will generally serve to deter that
wrong-doer and others who might be like-minded." 23
Canadian courts usually permit a plaintiff to elect between damages and
accounting of profits. 2  The remedy however is equitable; therefore, offering
this choice is at the court's discretion.12 The court may consider practical con-
sequences, including expediency,126 difficulties associated with ordering ac-
counting of profits,127 and misbehaviour by either a plaintiff or a defendant in
the course of litigation.128
In the past, a plaintiff was entitled to an accounting of profits, unless it was
shown that he or she had somehow disentitled himself or herself from it. More
recent case law, however, indicates that a patentee must show through positive
evidence that he or she is entitled to an accounting of profits.2 9 If an election is
permitted by the court, a plaintiffs decision must be made at the beginning of
the action, after discoveries, but before knowing which remedy the court will
determine to be the greater award. A plaintiff cannot subsequently re-elect for
the more profitable option. 3 ' The rule was affirmed in Schmeiser, where the
court held that "damages [were] not available, in view of Monsanto's election to
seek an accounting of profits." 31
An accounting of profits awards net profits incurred as a result of a defen-
dant's infringing activity. Where a defendant has been ordered to account for
123. Rivett, supra note 11 at para. 20.
124. AlliedSignal Inc. v. Du Pont Canada (1995), 95 F.T.R. 320 at para. 77 (F.C.A.)
[AlliedSignal ( 1995)].
125. Ibid. See also Apotex Inc. v. Wellcome Foundation Ltd. (1998), 145 F.T.R. 161 at para. 381
(F.C.T.D.) [Apotex], var'd on other grounds [2001] 1 F.C. 495 (F.C.A.), citing Beloit
(1997), supra note 95 at para. 111.
126. Apotex, ibid. at para. 384, citing Beloit (1997), ibid.
127. Ibid.
128. Norman Siebrasse et at., "Accounting of Profits in Intellectual Property Cases in Canada,"
(2008) 24 C.I.P.R. 82 at 119. For a revised and updated version, see Norman Siebrasse eta.,
"Accounting of Profits in Intellectual Property Cases in Canada" at 39, online: <http://www.
coleandpartners.com/pdf/Accounting.pdf>. See also Grenier & Steele, supra note 98 at para.
42; Dableh v. Ontario Hydro (1993), 67 F.T.R. 241 at paras. 121-25 (F.C.T.D.), rev'd on
other grounds (1996), 68 C.P.R. (3d) 129 (F.C.A.).
129. Grenier & Steele, ibid. at 43.
130. AlliedSignal (1995), supra note 124 at para. 77.
131. Schmeiser (2004), supra note 6 at para. 100.
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profits, the onus is on the plaintiff to prove the defendant's revenue generated
through patent infringement, 132 though a defendant may provide evidence of
the actual revenues received.133 The defendant must, by positive evidence, prove
legitimate deductions for expenses.
134
It is critical that defendants properly evidence expenses when this remedy is
sought. Failure to do so will dramatically affect any award granted. That ex-
plains the extraordinary per acre award in the Wouters decision, where the es-
sentially self-represented defendant provided no account of his revenues and a
woefully inadequate account of his expenses.13 Although courts have called for
"positive evidence" 3' when it comes to a defendant's obligation to account for
deductions, case law confirms that the court may take a "principled approach"
to assessing the quantum of allowable expenses. 37 Reasonable estimates of ex-
penses may even be accepted.'38 In AlliedSignal (1998), for example, the court
held that "[t]he fact that it is difficult to calculate the costs on a per-unit basis
... does not vitiate the Court's obligation to make its best estimate, and ulti-
mately to take such costs into account." 139 This was also the approach in agri-
cultural biotechnology patent cases, including Schmeiser, where the court
permitted a "reasonable allowance" for the unaccounted labour of the defen-
dant."04 In Rivett, the court permitted the defendant to deduct a portion of in-
put expenses, such as fertilizer and fuel, which were incurred in relation to the
infringing activity, but not easily disentangled from other non-infringing activi-
ties."' Although the courts seem inclined to take a principled approach to as-
132. Reading & Bates, supra note 120 at para. 16. See also Schmeiser (2003), supra note 9
at para. 81.
133. Siebrasse etal., supra note 128 at para. 8.
134. Schmeiser (2003), supra note 9 at para. 81. See also Teledyne, supra note 120; Rivett, supra
note 11 at para. 67.
135. Wouters, supra note 4 at para. 3.
136. Teledyne, supra note 120 at para. 11.
137. Riven, supra note 11 at para. 67.
138. Wellcome Foundation Ltd. v. Apotex (2001), 11 C.P.R. (4th) 218 at paras. 44-45 (F.C.A.)
[Wellcome Foundation (2001)].
139. Supra note 96 at para. 144.
140. Schmeiser (2001), supra note 29 at paras. 137-38, affd Schmeiser (2003), supra note 9 at
paras. 82-87.
141. Riven, supra note 11 at para. 68.
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sessing expense deductions, there are limits. In both Rivett and Janssens, the
court made it clear that the principled approach to assessing deductions is lim-
ited to the evidence before it.'42 That was also the case in Wouters.
143
No one would dispute that some expenses are properly deductible from
gross revenues in accounting for net profits to be disgorged. Controversy ex-
ists, however, over which expenses are deductible. The bulk of the case law
since the 1982 Teledyne decision has addressed this question. The basic ques-
tions courts have been asking are: (1) Which expenses were incurred because
of the infringing activity? and (2) Which expenses would have been incurred
in any event?
Courts have taken several different approaches. One approach suggests that
all expenses actually incurred are deductible against income. This is known as
the "full cost" approach,"' sometimes referred to by different courts and com-
mentators as the "absorption method" "5 of assessing deductible expenses. Other
courts have concluded that only expenses incurred because of the infringing ac-
tivity, which would not have incurred but for the infringement, are deductible
from income. This has been referred to in many cases and commentaries as the
"differential cost' 14 6 approach, as well as the "differential""4 7 approach, the "direct
cost" 4 8 method, the "differential profit" approach, the "variable cost" ap-
proach,' 9 and the "incremental""' method of assessing deductible expenses.
142. Ibid. at paras. 78, 81;Janssens, supra note 12 at paras. 33, 52.
143. Wouters, supra note 4 at para. 3.
144. See e.g. Diversified Products Corp. v. Tye-Sil Corp. (1990), 38 F.T.R. 251 at para. 2
(F.C.T.D.) [Diversified Products]; Beloit (1994), supra note 120 at para. 23; Wellome
Foundation Ltd. v. Apotex (1998), 151 F.T.R. 250 at para. 42 (F.C.T.D.) [Wellome
Foundation (1998)]; Baker Petrolite Corp. v. Canwell Enviro-Industries Ltd., [2002] 2 F.C. 3
at para. 161 (F.C.T.D.) [Baker Petrolite], rev'd on other grounds [2003] 1 F.C. 49 (F.C.A.);
and Rivett, supra note 11 at paras. 32-33.
145. See e.g. Diversified Products, ibid. at para. 2; Wellcome Foundation (1998), ibid. at para. 31;
and Rivett, ibid. at para. 28.
146. See e.g. Diversified Products, ibid.; Wellcome Foundation (1998), ibid; Jay-Lor, supra note 116
at para. 137; and Rivett, ibi.
147. See e.g. Baker Petrolite, supra note 144 at para. 161; Beloit (1994), supra note 120 at para. 23;
and Teledyne, supra note 120 at para. 15.
148. See e.g. Teledyne, ibid.
149. Siebrasse etal., supra note 128 at 15-17.
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Without diminishing the importance of the semantics, which are discussed
in detail below, the real controversy in assessing which expenses are deductible
to calculate net profits is a controversy over principle. The full cost method of
assessing expenses resembles the generally accepted accounting principles
(GAAP)."' All direct expenses, plus a reasonable proportion of indirect ex-
penses, are allowable deductions in calculating the costs associated with a par-
ticular product."2 The differential cost method accounts for all revenue, minus
only expenses that would not have occurred but for the infringing activity, thus
omitting indirect expenses from the equation.
The so-called "differential cost" method has generally been adopted as the
preferred approach since Teledyne. The court in that case decided that only ex-
penses directly attributable to the infringing activity should be accounted for:
"No part or proportion of any expenditure which would have been incurred
had the infringing operation not taken place, is to be considered as deducti-
ble."5 3 The court further held that:
[Jiustice requires that [the differential] method of determining net profits be
adopted. It would be contrary to the basic principles of equity to allow the in-
fringer to deduct, as opposed to the increase of fixed expenses attributable to the
infringing operation, such part of all its fixed costs as might be attributable pro-
vortionatelv to the operation. This would constitute in effect unjust enrichment of
the infringer.1
54
Courts have adopted this reasoning in subsequent cases. For example, in
Diversified Products Corp. v. Tye-Sil Corp., the court held that "[lt is well estab-
lished ... that a differential [cost] or incremental approach is appropriate to de-
termine an accounting of a defendant's [costs] in patent infringement cases."' 55
The "differential cost" method was also preferred in Wellcome Foundation
(1998), where the court held that:
150. See. e.g. Diversified Products, supra note 144 at para. 2; Wellcome Foundation (1998), supra
note 144 at para. 42;Jay-lor, supra note 116 at para. 137; and Rivett, supra note 11 at para.
28.
151. GAAP is the common set of accounting principles, standards, and procedures that are used
to compile financial statements in Canada and many other countries.
152. In the context of full cost accounting, see Siebrasse etaL, supra note 128 at 18.
153. Teledyne, supra note 120 at para. 9.
154. Ibid. at para. 7.
155. Supra note 144 at para. 3.
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No part or portion of any expenditure which would have been incurred had the
infringing activity not taken place is to be considered deductible. In this approach
only that portion of indirect costs or fixed costs that can fairly be attributable to
the infringing activity is deductible, as opposed to the absorption or full cost ap-
proach which provides for allocation of a portion of all indirect or fixed costs to be
attributed to that activity.
156
This approach has also been accepted in agricultural biotechnology patent
infringement cases, specifically. The Federal Court of Appeal stated in Schmeiser
(2003) that "the only costs to be taken into account are those directly associated
with the infringing activity."1"7
However, the amount actually awarded in Scbmeiser by the appellate court
appears to have been based on a standard income statement provided to the
court by Schmeiser's accounting expert witness. Because a standard income
statement allows deductions from a reasonable portion of indirect and fixed ex-
penses, the court really used the "full cost" method to account for expense de-
ductions. More precisely, the court allowed for deductions such as
"accounting," "insurance," "depreciation," and others, proportioned relative to
the acreage of infringing canola grown.15 Even though the court expressly pur-
ported to prefer the differential cost method in Schmeiser, it contradictorily ac-
cepted deductions that would normally only be permitted when using the full
cost approach. So it is not exactly true, as stated in Rivett, that: "If the full cost
approach has ever been endorsed by this Court, it has not been of late." '159 It
was actually adopted, albeit unintentionally perhaps, by the Federal Court of
Appeal in Schmeiser. There is probably no better proof than this of the serious
definitional and conceptual problems plaguing this area of the law.
One source of great confusion seems to involve basic accounting terminol-
ogy: fixed versus variable, capital versus current, direct versus indirect, and so
on. Take the discussion in Riveit as an example. Deductible expenses under the
differential cost approach were said to include "the variable or current expenses
directly attributable to the infringement and any increased, fixed or capital ex-
penses that are directly attributable to the infringement."6' In accounting par-
156. Wellcome Foundation (1998), supra note 144 at para. 42.
157. Supra note 9 at para. 81.
158. Schmeiser Financial Records, supra note 49.
159. Supra note 11 at para. 33.
160. Ibid. at para. 30.
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lance, variable expenses and current expenses are not synonymous terms, nor
are fixed expenses and capital expenses. It is not- clear whether Justice Zinn was
using them as such. What he really seemed to be saying is that, using the differ-
ential cost approach, all expenses-variable, current, increased, fixed, or capital-
that are directly attributable to the infringement, are deductible. He character-
ized the "full cost approach" as additionally allowing deductions for "the rele-
vant portion of the common costs incurred by the infringer."161 It seems what
he really meant by "common costs" were indirect costs.
Even the Teledyne decision at the root of this controversy used odd termi-
nology to distinguish a defendant's deductible expenses ("the'increase of fixed
expenses attributable to the infringing operation") from its non-deductible ex-
penses ("part of all its fixed costs attributable proportionately to the opera-
tion").162 The court seemed to mean variable costs when it used the unorthodox
phrase "increase of fixed expenses," but there also seems to have been some in-
tention to distinguish directness from indirectness with the vague language sur-
rounding "attributable" costs.
Similarly, in Wellcome Foundation (1998), a distinction was drawn between
"that portion of indirect costs or fixed costs that can fairly be attributable to the
infringing activity" (deductible) and "allocation of a portion of all indirect or fixed
costs to be attributed to that activity" (non-deductible).16 First, like variable and
current costs, or fixed and capital costs, indirect and fixed costs are not synonyms,
so they should not be used interchangeably. Fixed or variable costs can be direct
or indirect. Second, it is nonsensical to speak about fairly attributing indirect costs
to the infringing activity. If the costs are attributable (on a "but for" standard) to
the infringing activity, then they are properly called direct costs of that cost object.
The Federal Court of Appeal in Schmeiser (2003) came the closest to stating
the differential costs principle accurately (whether the principle is appropriate is
another matter) when it said, simply, that "the only costs to be taken into ac-
count are those directly associated with the infringing activity.""16 The court
muddied the waters when it said one thing and did another.
161. Ibid. at para. 32.
162. Teledyne, supra note 120 at para. 12.
163. Supra note 144 at para. 42.
164. Supra note 9 at para. 81.
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More generally, Professor Norman Siebrasse and his co-authors have cor-
rectly pointed out that the Teledyne decision should not be interpreted to rule
out the possibility of ever deducting indirect, fixed costs. They might be appro-
priately deductible in a case where the defendant can demonstrate that "but for
the infringement, some non-infringing opportunity would have been taken
up."165 Similar sentiments were expressed by Justice Zinn in Rivett. "In short,
Teledyne was a situation where the Court was assessing the profits made by an
existing business, by the addition of a new product line, where there was no
next best alternative available that would have generated profit.
166
Disallowing deductions for portions of fixed costs may make sense in rela-
tion to non-agriculture-related Canadian patent infringement cases because
such cases typically involve similar facts as Teledyne: a defendant who had alleg-
edly improperly used or made a patented invention in relation to a product line
that would not have existed otherwise. For example, in Diversified Products, the
court referred to the "differential [cost] method as being the proper approach to
determine the profit added to an existing business, as the result of the estab-
lishment of a new product line."167 In agricultural biotechnology patent in-
fringement cases, however, the infringing activity typically substitutes for a
readily available and rather similar non-infringing option. As a result, all or
most expenses would have been incurred if the infringement had not taken
place. Accordingly, there would be no, or few, deductible expenses, which
could result in an award of gross rather than net profits.
Although the terms and concepts just discussed were coined and adopted
by courts and commentators for the purpose of calculating the expenses which
should be deductible from income, problems are compounded because similar
language is sometimes used to differentiate various approaches to calculating
net profits, which depends on both attributable expenses and income. For ex-
ample, in Diversified Products, the court considered the "differential method as
being the proper approach to determine the profit.""6 8 So long as expenses were
the only relevant variable in calculating profits (i.e., speculative income com-
parisons were irrelevant), this language was fine. But the use of such terms by
165. Siebrasse etal., supra note 128 at 18.
166. Supra note 11 at para. 58.
167. Supra note 144 at para 3.
168. Ibid. [emphasis added].
6148 [2009) 47 OSGOODE HALL LAW JOURNAL
the Federal Court in Rivett, the court's most recent decision on this topic, is
confusing. Rivett considered "three possible approaches to determining the
profits of the infringer [including:] (a) The value based or differential profit ap-
proach; (b) The variable cost or incremental costs or differential cost approach;
and (c) The full absorption or full cost approach." 6 This framework obscures
the correlation between the parallel but distinct investigations into calculating
revenues and expenses that together determine profits.
Much of the recent confusion stems from remarks made by the Supreme
Court of Canada in Schmeiser, where, for the first time in Canada, it was held
that accounting of profits might involve a comparison of the benefits attribut-
able or not attributable to the patent infringement. The Court called this the
"differential profit "'70 approach, a term that had been used before. In looking at
the benefits of infringement, however, the Supreme Court opened the new pos-
sibility to differentiate between attributable and unattributable income.
Income differentials resulting from patent infringement could result from
higher prices for the product or, as is particularly relevant in the context of agri-
cultural biotechnology patents, higher yields. In general, this sort of analysis has
been referenced (though never adopted prior to Schmeiser) as the "value-based" 17 1
approach, the "comparative" '172 method, or the "apportionment" 173 method in
various cases.17 The Court in Schmeiser took the position that "the inventor is
only entitled to that portion of the infringer's profit which is causally attribut-
able to the invention." 175 In effect, the Schmeiser ruling limits potential claims
to actual profits earned from the infringing activity, minus those profits which
could have been made by using an available non-infringing alternative.
169. Rivett, supra note 11 at para. 28.
170. Schmeiser (2004), supra note 6 at para. 102. See also Rivett, supra note 11 at para. 29;
Janssens, supra note 12 at para. 25.
171. See e.g. Rivett, ibid. at para. 28.
172. See e.g. Reading & Bates, supra note 120 at para. 21; Wellcome Foundation (1998), supra note
144 at para. 31.
173. See e.g. Beloit (1994), supra note 120 at para. 72; Bayer, supra note 95 at para. 11.
174. Schmeiser (2004), supra note 6 at para. 101; Rivett, supra note 11 at para. 53; and Janssens,
supra note 12 at para. 25. See also Calgon Carbon Corp. v. North Bay (City) (2006), 304
F.T.R. 1 at para. 218 (F.C.T.D.) [Calgon Carbon].
175. Schmeiser (2004), ibid. at para. 101.
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The Supreme Court's acceptance of this approach represents a funda-
mental change in the method of calculating an award for accounting of prof-
its in some cases. In the decades before Schmeiser, courts had determined
"actual profits,"176 sometimes called "gross profits," as a simple matter of
fact. 7 The pre-Schmeiser jurisprudence is illustrated in Reading & Bates Con-
struction Co. v. Baker Energy Resources Corp., where the court rejected the de-
fendant's contention that profits are determined by comparing the profits
made from the infringing activity with those that could have been made from
a non-infringing alternative.178 It held, instead, that one must look at the
profits that were "actually made through the infringing acts," not the profits
that could have been made without infringement.179 A similar conclusion was
reached in Wellcome Foundation (2001),"8" citing the US Supreme Court deci-
sion of Tilghman v. Proctor8' as an authority. The court concluded that the
"comparative method" of assessing profits was too "speculative" and ignored
"actual profits earned by [the defendant] which the remedy to account for
profits is intended to capture."82
The Supreme Court of Canada in Schmeiser, however, held that a "com-
parison is to be made between the defendant's profit attributable to the inven-
tion and his profit had'he used the best non-infringing option."'83 Similar to
the Teledyne principle, where only expenses that would have not occurred but
for the infringement may be deducted from revenue, the so-called differential
profits approach essentially considers both revenues and expenses that would not
have been made but for the infringement. 84 The combination of factors that
176. See e.g. Beloit (1994), supra note 120 at para. 69; Reading &Bates, supra note 120 at para.
22; Wellcome Foundation (1998), supra note 144 at para 32; Bayer, supra note 95 at para. 14;
and Siebrasse etal., supra note 128 at 18.
177. See e.g. Rivett, supra note 11 at paras. 96, 98;Janssens, supra note 12 at para. 26.
178. Supra note 120 at para. 21.
179. Ibid. at para. 22.
180. Wellcome Foundation (2001), supra note 138 at para. 15.
181. 125 U.S. 136 (1888).
182. Wellcome Foundation (1998), supra note 144 at para. 37, affd Wellcome Foundation (2001),
supra note 138 at para. 19.
183. Schmeiser (2004), supra note 6 at para. 102.
184. Norman V. Siebrasse, "Accounting of Profits" CA Magazine 139:10 (December 2006) 45.
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might influence profitability-price, yield, and costs-is reflected in the follow-
ing statement from the Supreme Court:
Their (the defendants') profits were precisely what they would have been had they
planted and harvested ordinary canola. They sold the Roundup Ready Canola they
grew in 1998 for feed, and thus obtained no premium for the fact that it was
Roundup Ready Canola. Nor did they gain any agricultural advantage from the
herbicide resistant nature of the canola, since no finding was made that they
sprayed with Roundup herbicide to reduce weeds.
185
The novelty of the Schmeiser decision was an attribution of income (through
price and/or yield), not just costs, to particular infringing versus non-infringing
activities-or, more accurately, infringing versus non-infringing traits of the crop.
Subsequent case law and commentary has so far failed to frame the change in
this way. Nevertheless, this new approach now appears to be the preferred method
to calculate profits in recent Canadian patent infringement cases. In Rivett, Jus-
tice Zinn, after a lengthy analysis that discussed the merits of the method, ap-
plied the differential profits approach.'86 For the same reasons described in
Rivett, the differential profits approach was also employed in Janssens.'87
One of the problems in coming to terms with the Schmeiser approach is re-
lated to terminology. The Court in Schmeiser spoke about and adopted the "dif-
ferential profits" approach, which is easily confused with the "differential costs"
approach. The effects of these approaches could not be more different. Employ-
ing the differential costs approach reduces infringement-attributable deductions,
resulting in a higher accounting of profits. The differential profits approach re-
duces infringement-attributable income, as well as costs, potentially resulting in
a lower accounting of profits. Defendants in patent infringement cases would
want to support the differential profits and fAll cost approaches. Plaintiffs would
want to support the _full or actualprofits and differential cost approaches. Judges,
counsel, or anyone else cannot be blamed for being confused. The solution
proposed in this article is a rule of thumb requiring consistent application of
the differentialprofits approach to both income and costs, and, therefore, profits.
Siebrasse and his co-authors have pointed out, insightfully, that Schmeiser's
new approach to calculating comparative profits "does not require wholesale
185. Schmeiser (2004), supra note 6 at para. 104.
186. Rivett, supra note 11 at paras. 34-65.
187. Janssens, supra note 12 at para. 25.
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rejection of prior case law," and that the current and former approaches may
often converge in practice. 188 Specifically, pre-Schmeiser cases that calculate
profits to be accounted for attempted to allocate benefits attributable to in-
fringement indirectly by using complicated and inconsistent cost-based ap-
proaches." 9 Justice Zinn cited Siebrasse's work in correctly observing that it has
long been held "that there are occasions when, in spite of there being an in-
fringement, an accounting of profits, to be equitable, requires an apportion-
ment of the profits made between the infringer and the patentee."9'
Though it is true that, in some cases, the new approach may make little
difference, in other cases it may have a significant impact on awards. If an ac-
counting of profits is elected, the differential profits approach may even lead to
circumstances where a plaintiff will not be entitled to any award, such as in
Schmeiser, where the defendant used, but did not benefit financially from, the
patented technology. 9' In other circumstances, 'a zero award may be granted if
a defendant successfully argues that the plaintiffs invention does not measura-
bly increase revenue or decrease costs compared to non-infringing options.
In both Rivett and Janssens, the court differentiated the actual profits
from infringement and the hypothetical profits from non-infringement based
on the testimony of the plaintiff's witness quantifying the benefits of
Roundup Ready over conventional soybeans. 92 There are different, credible
opinions about the extent to which genetically modified crops affect relative
profitability. Some sources indicate that Roundup Ready soybeans offer no
measurable returns per acre advantage compared to conventional options.
1
'
3
The government of Ontario suggests that modest benefits are causally attrib-
utable to Roundup Ready soybeans. 9 ' According to OMAFRA budgeting
188. Siebrasse etal., supra note 128 at 2.
189. Ibid. at 112-14.
190. Rivett, supra note 11 at para. 46.
191. Ibid. at para. 47.
192. Ibid at para. 99;Janssens, supra note 12 at para. 50.
193. Mike Duffy, "Does Planting GMO Seed Boost Farmers' Profits?" Leopold Letter 11:3 (Fall
1999), online: Leopold Centre for Sustainable Agriculture, Iowa State University
<http://www.leopold.iastate.edu/pubs/nwl/1999/1 999-3-leoletter/99-3gmoduffy.htm>.
194. The government of Ontario was also the same source Monsanto used to estimate the crop
yields and prices for the defendant's soybean production in the Wouters case. Wouters, supra
note 4 at para. 6.
652 (20091 47 OSGOODE HALL LAW JOURNAL
tools, 9 ' Roundup Ready soybeans only produce an expected 7 per cent net
profit improvement over conventional beans grown using "no-till" cultivation
methods.
There are other considerations that complicate an analysis of differential
profits in the context of agricultural biotechnology patent cases. Courts will
consider profits relative to the next best non-infringing alternative, but pre-
cisely how this comparison should be made is unclear. It may be that the best
non-infringing alternative is a licence to use the patented technology. In such
cases, calculating the differential profits should be simple: it should be the
royalty rate which was avoided by infringing rather than licensing. If this ap-
proach were adopted, electing an accounting of profits or an award of dam-
ages should generate identical remedies. Justice Zinn explicitly rejected this
approach as inappropriate because it would provide no deterrent to potential
infringers. As it relates to profits to be disgorged in agricultural biotechnol-
ogy patent infringement cases, "the comparison is not to the profits that
Rivett would have generated had he legally bought the Roundup Ready soy-
bean seed and purchased the license; it must be to soybean seed that has
none of the plaintiffs' invention. Thus, conventional soybean is the appro-
priate comparator. "
'196
Perhaps, alternatively, the next best non-infringing option would be to
grow certified organic crops rather than genetically modified crops. In Rivett,
Justice Zinn held: "The advantage of the plaintiffs' invention does not lie in the
uniqueness of the bean; the fact that it contains the plaintiffs' gene adds no
value at the time of sale. It is worth the same as the bean without the gene.""9 7
Possibly, however, a bean containing molecularly engineered genes and cells
would be worth less than a bean without the gene. The price differential be-
tween organic and genetically modified crops can be significant in some mar-
kets.1 98 The next best non-infringing option for a farmer could actually lead to
greater net profits than the infringing option.
195. OMAFRA, "Budgeting Tools," online: <http:lwww.omafra.gov.on.calenglishlbusdevl
bear2000/Budgers/budgettools.htm>.
196. Rivett, supra note 11 at para. 57.
197. Ibid at para. 62.
198. William D. McBride & Catherine Greene, "The Profitability of Organic Soybean
Production" (Paper presented at the American Agricultural Economics Association Annual
Meeting, Orlando, Florida, July 27-29, 2008) [unpublished].
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Even if a plaintiff could successfully show the court that patented seed
technology provides significant benefit compared to non-infringing alternatives,
a plaintiff may still risk realizing a small or no award when an accounting for
profits is the elected remedy. There is a chance that a defendant did not realize
any profit in the course of infringement. In addition, it does not matter whether
or not a defendant could or should have made a profit by using the patented
technology; an award is only available if the infringer did make a profit.199
Given that a plaintiff's choice between damages and an accounting for
profits cannot depend on whichever amount is ultimately decided to be
higher,"' and given that a quantum of damages, if elected, is almost certain in
cases where licensing fees are well established,2"' electing for an accounting for
profits can be a gamble. The choice is essentially between a more certain award
of damages and a less certain, but potentially larger, award of accounting for
profits. The risk may be particularly high when an accounting for profits is
elected in cases involving agricultural biotechnology. Farming is an inherently
risky endeavour; it is especially vulnerable to uncontrollable weather conditions,
perishable products, and volatile commodity prices, all of which may adversely
affect profitability. From one year to the next, farmers and farming businesses
in Canada, regardless of size, efficiency, or location, may go from a high profit
margin one year to a net loss the next. For example, recent rises in agricultural
commodity prices provided Canadian farmers with relatively high net profits in
2008,202 while conditions over the previous several years caused many, if not
most, Canadian farmers to operate at the margins of profitability.23
199. Siebrasse etal., supra note 128 at 3.
200. AlliedSignal(1995), supra note 124 at para. 81.
201. AlliedSignal (1998), supra note 96 at para. 22.
202. Ashleigh Patterson, "Canada Net Farm Income Up on Grain Prices" Calgary Herald (26
May 2008), online: <http://www.canada.com/calgaryherald/news/story.html?id=
aa0640de-f310-42a9-9524-cc5l2dO9db9c>. Soybean prices have more than doubled
between May 2006 and May 2008. See Brazilian Association of Vegetable Oil Industries,
"Soybean Complex Average Prices -2008" (10 June 2008), online: <http://www.abiove.
com.br/english/cotacoes us 08.html>.
203. Canada, Senate, Standing Senate Committee on Agriculture and Forestry, Beyond Freefall:
Halting Rural Poverty (June 2008) at 37, online: <http://www.parl.gc.ca/39/2/parlbus/
commbus/senate/com-e/agri-e/rep-e/repO9jun08-e.pdf> (Chairs: Joyce Fairbairn & Leonard
J. Gustafson). See also National Farmers Union, Press Release, "Ag. Policy Framework Years
Worst in Ontario History" (14 February 2007), online: <http://www.nfii.ca/press_releases/
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Plaintiffs in cases involving agricultural biotechnology patent infringement
should take care when reviewing defendants' disclosures pertaining to income.
If it is possible that a defendant has had an unprofitable year, then a plaintiff
should be cautious about pursuing an award based on accounting for profits. In
such cases, if an accounting for profits is elected, a plaintiff may realize nothing.
IV. SUMMARY, SOLUTIONS, AND IMPLICATIONS
Remedies in Canadian agricultural biotechnology patent infringement cases
have generally been consistent with other Canadian patent infringement cases.
In addition to injunctive relief and orders to destroy infringing goods, available
remedies include general damages, punitive damages, and accounting of profits.
Plaintiffs usually have the option to seek either damages or accounting of prof-
its, but not both.
If damages are elected and infringement is found, a court will normally
award an amount equal to the product's ordinary licensing fees. Canadian courts
are generally reluctant to award punitive damages in patent cases. Given that
merely intentional infringement does not justify punitive damages, it is hard to
imagine a case where a Canadian farmer would have to pay such an award.
If an accounting of profits is elected, then the amount of an award would
depend on a defendant's profits attributable to the infringement. In the case of
agricultural biotechnology patents, this will depend on whether and how much
the infringing farmer benefited from the patent. Canadian courts have recently
accepted the differential profits approach in assessing profits to be disgorged.
An award will be based on only the portion of profits that would not have
arisen but for the infringing activity.
One of the underlying problems impeding conceptual clarity in this area of
the law seems to be the inability of courts to disentangle legal and financial prin-
ciples. For example, different legal approaches have been used to calculate actual
or differential expenses and actual or differential profits. A part of this problem
is the courts' failure to distinguish adequately between discussions of income, ex-
penses, and profits. Profits should be the paramount consideration for courts
calculating the value of awards. Much of the early jurisprudence, however, focused
on issues pertaining to expenses. Until recently, no court had ever decided that
press/2007/February-07/AgPolicyFramework coincideswith-worst_5_yearsof_
Ontari%5B1%5D.pdf>.
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it was necessary or appropriate to distinguish income earned as a result of in-
fringement and income that might have been earned otherwise. Consequently,
merely determining which expenses were allowable as deductions from total in-
come earned would determine the profits to be disgorged. This led to the use of
loose language. While courts were only concerned with deductible expenses,
because speculative income comparisons were considered irrelevant, both ex-
penses and profits were referenced interchangeably.
Uncertainty about the distinct legal treatment of infringement-attributable
expenses and infringement-attributable income could be excused, but if that is
really the crux of the debate, then people seem to be confused more by the lan-
guage they employ than by the principles at issue. Controversy over a princi-
pled distinction seems silly when one realizes that, from an accounting
perspective, profit (or net income) is nothing other than gross income less ex-
penses. Whichever approach is used to calculate profits should subsume the
identical approach toward expenses and toward income. Consistency among
approaches to calculating differential expenses, differential income, and, there-
fore, differential profits is the first step toward coherence in this area of the law.
Linguistic precision is another prerequisite for conceptual coherence. In the
simplest language possible, the practical matter to be decided is whether an in-
fringing defendant must disgorge all profits or only those profits attributable to
the infringement. If disgorgement should equal only profits attributable to the
infringement-which courts and commentators seem to universally accept-
the next question must address how to distinguish infringement-attributable
profits from other profits.
Basic accounting concepts can direct courts through a simple two-step an-
swer to this question. The first step is an inquiry comparing income created by
patent infringement and income that would have been earned otherwise. Income
differentials could be the result of price premiums, production yields, competitive
advantages in the marketplace, or other factors. The second step investigates the
relative cost advantages of infringement over non-infringement. The key issue
should be whether the costs are directly or indirectly related to the infringement,
not whether they are fixed or variable, increased or not, capital or current, or any-
thing else. Courts should jettison any imprecise language taken from previous ju-
risprudence in order to focus on the key principle of attribution.
With judges and counsel better prepared to deal with the definitional and
conceptual difficulties in this area of the law, a remaining task is to provide
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more accurate information about available patent infringement remedies to pat-
entees, farmers, and the general public. Sophisticated public relations cam-
paigns regarding awards have been promoted in a potentially misleading
manner. The fact that the patentee received no accounting of profits following
the Supreme Court's decision in Schmeiser is generally unknown among farm-
ers, while the trial level consent judgment of $160 per acre in Beneteau, the de-
fault judgment of $274 per acre in Wouters, and the $200 per acre settlement
against three Quebec farmers have been recently publicized in farm publica-
tions. Such extraordinarily high awards are proclaimed as seminal precedents,
despite being the result of consent and default judgments. The Federal Court of
Appeal's award in Schmeiser of approximately $19 per acre," 4 the $42 per acre
award in Rivett,20 5 and the average $48 per acre award in Janssens20 6 are all closer
to the norm that future defendants might expect to pay and plaintiffs might
expect to receive.
Although it is understandable that patent owners would not publicize the
outcomes of settlements and judgments less favourable to their interests, the
capacity to promote a distorted version of the norm affects conventional beliefs
among farmers and creates an impression that large awards are typical in these
cases. These beliefs may then contribute to exaggerated fears held by farmers
facing possible litigation. This increased fear could lead to a greater likelihood
of settlement agreements that are disproportionate to the harm caused by the
infringement and the potential liability facing infringers.
Moreover, promoting the impression that patent infringement damage
awards are routinely higher than they really are, or would be in most cases, is
detrimental to those who rely on the integrity and predictability of the patent
system. Other patent owners and the investors who fund innovative research
and development deserve an accurate portrayal of the amounts that can be real-
istically expected in normal infringement proceedings. Information conveyed to
and through the media is misleading in this respect.
In sum, farmers facing patent infringement claims are in a much stronger
legal position than Monsanto and the media seem to suggest. This realization,
204. Schmeiser (2003), supra note 9 at paras. 84, 87.
205. Rivett, supra note 11 at para. 102.
206. Janssens's numbers in this article are based on the amended reasons for judgment, which are
very close to the values set inJanssens, supra note 12 at para. 51. See Monsanto Canada Inc. v.
Janssens, [2009] F.C.J. No. 1355 (Q.L.).
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however, triggers antecedent questions about whether the status quo is sustain-
able or even desirable as a matter of public policy. For innovative firms re-
searching and developing new technologies, and the investors that support such
endeavours, serious concerns emerge about the real effectiveness of patent en-
forcement techniques. Indeed, a refined understanding of actual remedies avail-
able, based on the revelations in this article, could make businesses' patent
portfolios vulnerable to revaluation, both financially and strategically.
Given this possibility, it appears that both the courts and policy makers
could face pressures to reform patent law. For courts confronted with the di-
lemma of ineffective infringement remedies, one option might be to make pu-
nitive damages more frequently available. Meanwhile, legislators are likely to be
pressured to adopt another solution: the introduction of statutory damages of
the sort available for infringements of other intellectual property rights, most
notably copyright.
The consequences of law reform for farmers facing infringement allegations
could be grave. Such farmers may currently believe they are in a vulnerable legal
position, but, as this article demonstrates, that is not really so. Paradoxically,
revealing the real strength of accused farmers' bargaining posture may under-
mine their legal position in the longer term.
This article points out some implications of realizing the conceptual and
practical challenges that exist in determining remedies for agricultural biotech-
nology patent infringement. Its principal contribution has been to identify a
previously under-recognized problem, analyze its underlying causes and effects,
and propose simple strategies to reduce complexity and facilitate coherence.
This framework enables clearer insights into the broader implications of the
remedy of accounting of profits for agricultural biotechnology patent infringe-
ment, and lays the groundwork for future scholarly work and rational jurispru-
dence in this area.
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APPENDIX A: DEDUCTIBLE EXPENSES IN RECENT CASES
Expenses Schmeiser Riett Janssens
Herbicide Yes Yes Yes
Fcrtilizer Yes Yes Yes
Soil Treatment Yes Yes Yes
Crop Insurance Yes Yes Yes
Land Rent Yes Yes Yes
Property Tax Yes
Labour Yes No No
Fuel Yes Yes
Equipment Repairs Yes
Utilities Yes No
Trucking Yes
Insurance Yes No
Office Expenses Yes
Legal/Accounting Yes
Salaries Yes
Meetings/Tra(,el Yes
Workers Compensation Yes
Interest on Loans Yes No
Depreciation Yes No
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APPENDIX B: FINANCIAL DETAILS AND ACCOUNTING FOR
PROFITS IN RIVETTAND JANSSENS
TABLE 1: ACCOUNTING FOR PROFITS IN RIVETT CHARLES RIVETT
Acres Grown 947
Revenue $233,311.73 $246.37
Expenses
Land Rent (allowed on 628 acres only) $44.795.62 $47.30
Fuel $7,916.92 $8.36
Fertilizer $15,379.83 $16.24
"Seaweed" Fertilizer $4,261.50 $4.50
"Hystick" Inoculant $4,574.01 $4.83
Carbon $700.78 $0.74
Herbicide $13,317.19 $14.06
Crop Insurance $12,888.67 $13.61
Total Expenses $103,834.52 $'109.65
Total Net Profit $129,477.21 $136.72
Total Differential Profit at 31% $40,137.94 $42.38
TABLE 2: ACCOUNTING FOR PROFITS IN JANSSENS: DEFENDANTS COLLECTIVELY
Per Acre
Average2004
Acres Grown 50 250 300
Revenue $10,241.00 $80,961.70 $91,202.70 $304.01
Total Expenses $0.00 $44,307.50 $44,307.50 $147.69
Total Net Profit $10,241.00 $36,654.20 $46,895.20 $156.32
Total
Differential
Profit at 31% $3,174.71 $11,362.80 $14,537.51 $48.46
2005
Per Acre2004
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TABLE 3: ACCOUNTING FOR PROFITS IN JANSSEN: ALAN KERKHOF
2005 Total
Per Acre
Average
Acres Grown 20 100 120
Revenue $4,096.40 $32,384.68 $36,481.08 $304.01
Expenses
Herbicide $0.00 $1,095.00 $1,095.00 $10.95
"Touch Down" $0.00 $730.00 $730.00 $7.30
Fertilizer $0.00 $4,050.00 $4,050.00 $40.50
Ammonium
Sulphate $0.00 $180.00 $180.00 $1.80
"Matador" $0.00 $542.00 $542.00 $5.42
"Agral" $0.00 $83.00 $83.00 $0.83
Crop Insurance $0.00 $1,043.00 $1,043.00 $10.43
Rent $0.00 $12,500.00 $12,500.00 $125.00
Total Expenses $0.00 $20,223.00 $20,223.00 $202.23
Total Net Profit $4,096.40 $12,161.68 $16,258.08 $101.78
Total
Differential
Profit at 31% $1,269.88 $3,770.12 $5,040.00 $42.00
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TABLE 4: ACCOUNTING FOR PROFITS IN JANSSENS: LAWRENCE JANSSENS
2004 2005 Total
Per Acre
Average
Acres Grown 20 100 120
Revenue $4,096.40 $32,384.68 $36,481.08 $304.01
Expenses
Herbicide $0.00 $1,095.00 $1,095.00 $10.95
"Touch Down" $0.00 $730.00 $730.00 $7.30
Fertilizer $0.00 $4,050.00 $4,050.00 $40.50
Ammonium
Sulphate $0.00 $180.00 $180.00 $1.80
"Matador" $0.00 $542.00 $542.00 $5.42
"Agral $0.00 $83.00 $83.00 $0.83
Crop Insurance $0.00 $1,043.00 $1,043.00 $10.43
Rent $0.00 '$12,500.00 $12,500.00 $125.00
Total Expenses $0.00 $20,223.00 $20,223.00 $202.23
Total Net Profit $4,096.40 $12,161.68 $16,258.08 $101.78
Total
Differential
Profit at 31% $1,269.88 $3,770.12 $5,040.00 $42.00
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TABLE 5: ACCOUNTING FOR PROFITS IN JANSSENS: RONALD JANSSENS
2004 2005 Total
Per Acre
Average
Acres Grown 10 50 60
Revenue $2,048.20 $16,192.34 $18,240.54 $304.01
Expenses
Herbicide $0.00 $547.50 $547.50 $10.95
"Touch Down" $0.00 $365.00 $365.00 $7.30
Fertilizer $0.00 $2,025.00 $2,025.00 $40.50
Ammonium $0.00 $90.00 $90.00 $1.80
Sulphate
"Matador" $0.00 $271.00 $271.00 $5.42
"Agral" $0.00 $41.50 $41.50 $0.83
Crop Insurance $0.00 $521.50 $521.00 $10.43
Rent $0.00 $0.00 $0.00 $0.00
Total Expenses $0.00 $3,861.50 $3,861.50 $77.23
Total Net Profit $2,048.20 $12,330.84 $14,379.04 $226.78
Total
Differential
Profit at 31% $634.94 $3,822.56 $4,457.50 $74.29
